Medicare Enrolled
Dr. Tony Mammen, MD
Optician · Arlington, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mammen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mammen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mammen
Dr. Tony Mammen is an optician specialist in Arlington, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mammen performed 2,258 Medicare services across 1,684 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mammen received a total of $5,932 from 42 pharmaceutical and/or device companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mammen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 28% volume in TX
$5,932 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,258
Medicare services
Top 28% in TX for optician
1,684
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~125 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
531 | $88 | $288 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
221 | $7 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
177 | $6 | $13 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
177 | $2 | $5 |
| PSA test (prostate cancer screening) | 141 | $18 | $41 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
90 | $67 | $298 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
87 | $184 | $547 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $117 | $377 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
71 | $30 | $110 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
69 | $3 | $8 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
67 | $18 | $41 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
60 | $34 | $325 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
60 | $34 | $184 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $60 | $202 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
49 | $8 | $19 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
46 | $6 | $14 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
30 | $34 | $79 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
30 | $34 | $79 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
30 | $34 | $79 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
30 | $34 | $79 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
30 | $34 | $79 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
30 | $34 | $79 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $131 | $420 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
22 | $638 | $1,842 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
19 | $18 | $53 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
14 | $25 | $57 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $237 | $735 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
9.8% medium
89.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,932
Total received (2018-2024)
Avg $847/year across 7 years
Top 24% in TX for optician
42
Companies
199
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,818 (98.1%)
Scientific / Research
Research funding and grants
$114 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,889
2023
$818
2022
$745
2021
$628
2020
$615
2019
$822
2018
$414
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$1,350
Astellas Pharma US Inc
$615
Janssen Biotech, Inc.
$439
BIOTISSUE HOLDINGS, INC.
$373
Boston Scientific Corporation
$266
ABBVIE INC.
$263
C. R. Bard, Inc. & Subsidiaries
$220
Blue Earth Diagnostics Limited
$217
Teleflex LLC
$185
Myovant Sciences Inc.
$184
Axonics, Inc.
$142
Sun Pharmaceutical Industries Inc.
$137
Sumitomo Pharma America, Inc.
$129
NeoTract Inc.
$117
Endo Pharmaceuticals Inc.
$108
Dendreon Pharmaceuticals LLC
$100
Ferring Pharmaceuticals Inc.
$98
Coloplast Corp
$97
Merck Sharp & Dohme Corporation
$91
Janssen Scientific Affairs, LLC
$84
Olympus America Inc.
$82
AbbVie, Inc.
$70
Verity Pharmaceuticals Inc.
$52
Bayer Healthcare Pharmaceuticals Inc.
$50
Innovation Technologies Inc
$48
Antares Pharma, Inc.
$46
HealthTronics Mobile Solutions, LLC
$41
TOLMAR Pharmaceuticals, Inc.
$35
Agiliti Surgical, Inc.
$30
Clarus Therapeutics Inc.
$30
AngioDynamics, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$27
Amgen Inc.
$26
UroGen Pharma, Inc.
$24
UROVANT SCIENCES INC
$22
Duchesnay USA Incorporated
$18
GENZYME CORPORATION
$18
Myriad Genetic Laboratories, Inc.
$16
180 Medical, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$14
Progenics Pharmaceuticals, Inc.
$13
PFIZER INC.
$11
Top 3 companies account for 40.5% of total payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · AVEED · Axonics · Axumin · BOTOX · Bulkamid · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENTLECATH · IRRISEPT · Inlay · Isiris aStent Removal Device · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron Depot · MYRBETRIQ · Mobile Laser Services · NANOKNIFE · NEOX · NOCDURNA · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Osphena · PROVENGE · PYLARIFY · Prolaris · Prolia · SpeediCath · Trelstar · UROLIFT · UroLift · VESICARE · XIAFLEX · XTANDI · Xofigo · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $263 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
293
Per 100K population
13.7
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mammen is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mammen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mammen performed 531 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mammen receive payments from pharmaceutical companies?
Yes. Dr. Mammen received a total of $5,932 from 42 companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mammen's costs compare to other opticians in Arlington?
Dr. Mammen's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mammen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Arlington
Browse opticians in Arlington ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology